In a historic medical breakthrough, a three-year-old child has become the youngest patient ever to receive a revolutionary ...

As Massachusetts public health leaders address gambling addiction, one Scandinavian country offers solutions that put more ...

A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and ...

Najpierw wprowadzenie podatku akcyzowego na saszetki nikotynowe, potem propozycja przepisów, które zmierzają do wycofania tych produktów z rynku – przedstawiciele środowisk ...

Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an ...

Mouse models are central to drug development, including treatments for neurological disorders, such as Parkinson's disease.

The new study surveyed 634 people with Parkinson’s disease, or PD. It finds that people with PD report that tremor is one of ...

Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.

In his 29 years as a faculty member in the Department of Neurology, Nicholas established himself as a leader in the field of movement disorders on both clinical and research fronts, all while acting ...

- $60 million Series A led by Atlas Venture, and founded by an expert team of physicians and scientists - VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently ...